|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61N 1/30 | |
| A61N 1/04 | |||
| A61N 1/18 | |||
| A61N 1/32 | |||
| A61M 37/00 | |||
| A61K 9/00 |
| (11) | Patento numeris | 2396073 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10741574.7 |
| Europos patento paraiškos padavimo data | 2010-02-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-12-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/023112 |
| Data | 2010-02-03 |
| (87) | Numeris | WO 2010/093546 |
| Data | 2010-08-19 |
| (30) | Numeris | Data | Šalis |
| 537243 | 2009-08-06 | US | |
| 152251 P | 2009-02-12 | US |
| (72) |
IMRAN, Mir, US
|
| (73) |
Incube Labs, LLC,
2051 Ringwood Avenue, San Jose, CA 95131,
US
|
| (54) | IONTOPHORETIC SYSTEM FOR TRANSDERMAL DELIVERY OF ACTIVE AGENTS FOR THERAPEUTIC AND MEDICINAL PURPOSES |
| IONTOPHORETIC SYSTEM FOR TRANSDERMAL DELIVERY OF ACTIVE AGENTS FOR THERAPEUTIC AND MEDICINAL PURPOSES |